The potential for misuse among those taking it for medical reasons is controversial, with some expert reviews stating that the risk is low and similar to that of other benzodiazepine drugs. Overdoses of alprazolam can be mild to severe depending on the quantity ingested and if other drugs are taken in combination. Like all central nervous system depressants, alprazolam in larger-than-normal doses can cause significant deterioration in alertness and increase drowsiness, especially in those unaccustomed to the drug's effects. The effect size (Hedges's g) of alprazolam for the treatment of panic disorder based on the five clinical trials was 0.33 (a small effect) and based on the published trials was 0.47 (a moderate effect), equating to an increase of 0.14 or 42%. In Australia, alprazolam is not recommended for the treatment of panic disorder because of concerns regarding tolerance, dependence, and abuse. Alprazolam is indicated for the treatment of generalized anxiety disorder (GAD) and panic disorder with or without agoraphobia in adults.
1 Risks From Concomitant Use With Opioids
In either case, it is presumed that the prescribed dose is not sufficient to maintain plasma levels above those needed to prevent relapse, rebound, or withdrawal symptoms over the entire course of the interdosing interval. Patients at an increased risk of withdrawal adverse reactions after benzodiazepine discontinuation or rapid dosage reduction include those who take higher dosages, and those who have had longer durations of use. To reduce the risk of withdrawal reactions, use a gradual taper to discontinue XANAX or reduce the dosage (a patient-specific plan should be used to taper the dose) see Dosage and Administration (2.3).
CLINICAL STUDIES
Anecdotally, injection of alprazolam has been reported, causing dangerous damage to blood vessels, closure of blood vessels (embolization), and decay of muscle tissue (rhabdomyolysis). Regarding the significant increases detected, it is worthwhile to consider that the number of pharmaceuticals dispensed for legitimate therapeutic uses may be increasing over time, and DAWN estimates are not adjusted to take such increases into account. The number of emergency department visits due to benzodiazepines increased by 36% between 2004 and 2006. The report found that alprazolam is the most common benzodiazepine for recreational use, followed by clonazepam, lorazepam, and diazepam.
Lifestyle Quizzes
The active ingredient in Xanax is alprazolam, while the active ingredient in clonazepam is clonazepam. The active ingredient in Xanax is alprazolam, while the active ingredient in Valium is diazepam. They can tell you about other medications that may work well for you. To learn more, see the “Xanax dependence and withdrawal” section. With dependence, your body becomes reliant on a drug to function as usual. Also, be sure to contact your doctor as soon as possible if you have any symptoms of misuse or addiction, or any concerns about them.
Both Xanax and CNS depression may lead to side effects such as lack of coordination and drowsiness. The list below includes some factors to consider. Before you take Xanax, discuss your health history with your medical professional. If you have certain medical conditions or other factors that affect your health, Xanax may not be the right choice for you. Your medical professional or pharmacist can provide more details as well as information on other possible interactions.
They’ll ultimately prescribe the lowest dosage of Xanax that’s needed to relieve your symptoms of panic disorder. The typical starting dosage of Xanax for panic disorder is 0.5 mg three times per day. The typical starting dosage of Xanax for generalized anxiety disorder (GAD) is 0.25 mg to 0.5 mg three times per day.
Alprazolam exerts its effect for the acute treatment of generalized anxiety disorder and panic disorder through binding to the benzodiazepine site of gamma-aminobutyric acid-A (GABAA) receptors in the brain and enhances GABA-mediated synaptic inhibition. Physical dependence is a state that develops as a result of physiological adaptation in response to repeated drug use, manifested by withdrawal signs and symptoms after abrupt discontinuation or a significant dose reduction of a drug. Because of the potential for serious adverse reactions, including sedation and withdrawal symptoms in breastfed neonates and infants, advise patients that breastfeeding is not recommended during treatment with XANAX. In many of the spontaneous case reports of adverse behavioral effects, patients were receiving other CNS drugs concomitantly and/or were described as having underlying psychiatric conditions. For the same reason, patients should be cautioned about the concomitant use of alcohol and other CNS depressant drugs during treatment with XANAX see Drug Interactions (7.1).
1 Risks From Concomitant Use With Opioids
Other uses include the treatment of chemotherapy-induced nausea, together with other treatments. The half-life of alprazolam is 12 to 15 hours, but that of clonazepam is 18 to 50 hours, so the effect of alprazolam is faster, but that of clonazepam is longer lasting in time. The drug is usually presented in orange or bluish-colored tablets, cylindrical, biconvex, and slotted on one side to facilitate taking the appropriate doses. The patient should inform the doctor about all the medications he/she is using since the drug can interact with many other medications. Therefore, it is recommended to start treatment with very low doses.
The 6 Stages Of Mental Health Recovery
Therefore, dosage reduction of XANAX is recommended in geriatric patients see Dosage and Administration (2.4) and Clinical Pharmacology (12.3). At this time, there is no clear evidence that alprazolam exposure in early pregnancy can cause major birth defects. Monitor neonates exposed to benzodiazepines during pregnancy and labor for signs of sedation, respiratory depression, withdrawal, and feeding problems and manage accordingly see Warnings and Precautions (5.4).
